Diazon Pharmaceuticals is Drug Discovery in Canada that focus on developer business. Founded in 2013. They cover business area such as developer, onco-therapeutic drug, treatment, metastatic triple-negative breast cancer, microtubule structure, dynamic, potent anti-tumor efficacy, an unusual safety profile, lack, neurotoxicity, pre-clinical model, clinician, cancer cell, improved safety margin.
2013
( 11 years old in 2024 )
Developer
-
1010 Sherbrooke Street West
Suite 408
Montreal, Quebec H3A 2R7
Canada
Private
developeronco-therapeutic drugtreatmentmetastatic triple-negative breast cancermicrotubule structuredynamicpotent anti-tumor efficacyan unusual safety profilelackneurotoxicitypre-clinical modelcliniciancancer cellimproved safety margin
* We use standard office opening hours in near Diazon Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Diazon Pharmaceuticals is Drug Discovery business from Canada that founded in 2013 (11 years old in 2024), Diazon Pharmaceuticals business is focusing on Developer.
Diazon Pharmaceuticals headquarter office and corporate office address is located in 1010 Sherbrooke Street West Suite 408 Montreal, Quebec H3A 2R7 Canada.
Diazon Pharmaceuticals was founded in Canada.
In 2024, Diazon Pharmaceuticals is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Diazon Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
